GO:0045008 depyrimidination: DNA Base Loss Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045008 depyrimidination is the biological process in which the glycosidic bond between the deoxyribose sugar and a cytosine (C) or thymine (T) base is broken, releasing the base and leaving an apyrimidinic (AP) site in DNA.
• Depyrimidination is a spontaneous and heat-induced hydrolytic reaction that occurs in neutral solution, with cytosine and thymine bases being lost from the DNA backbone.
• The relative ease of thermolytic depyrimidination versus depurination has been characterized in 2'-deoxynucleosides, showing that pyrimidine loss is a measurable chemical event.
• Chemical substituents such as 5-halo groups on 2'-deoxyuridines influence the rate of thermal depyrimidination of the glycosidic bond.
• Enzymatic depyrimidination is catalyzed by enzymes such as human thymidine phosphorylase, which cleaves thymidine in an arsenolytic reaction.
• Depyrimidination hotspots correlate with base substitution mutations induced by agents such as neocarzinostatin chromophore, linking this process to mutagenesis.
Description
Depyrimidination (GO:0045008) is a fundamental DNA damage process defined as the disruption of the bond between the sugar in the backbone and the C or T base, causing the base to be removed and leaving a depyrimidinated sugar. This hydrolytic event generates apyrimidinic (AP) sites, which are cytotoxic and mutagenic lesions that must be repaired to maintain genomic integrity. Understanding depyrimidination is essential for researchers studying DNA repair, mutagenesis, and the chemical stability of nucleic acids. The process occurs spontaneously under physiological conditions and is accelerated by heat, making it a constant threat to genome stability. In addition to spontaneous hydrolysis, depyrimidination can be catalyzed enzymatically, for example by human thymidine phosphorylase, which cleaves thymidine to thymine and 2-deoxy-D-ribose 1-phosphate. The biological significance of depyrimidination extends to mutagenesis, as hotspots of base loss correlate with sites of base substitution mutations induced by DNA-damaging agents such as neocarzinostatin chromophore. Furthermore, the chemistry of depyrimidination is influenced by substituents on the pyrimidine ring, as shown by studies on 5-halo substituents in 2'-deoxyuridines. Methodologically, depyrimidination has been exploited in analytical chemistry, for instance in a one-pot fluorescence tagging and depyrimidination strategy for quantification of global DNA methylation. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of depyrimidination, its mechanisms, associated genes, disease relevance, and experimental models for CRISPR-based investigation.
depyrimidination At A Glance
| GO ID | GO:0045008 |
|---|---|
| GO term | depyrimidination |
| Ontology | biological_process |
| Synonym | None |
| Major function | Removal of cytosine or thymine bases from DNA, creating apyrimidinic (AP) sites |
| Chemical nature | Hydrolytic cleavage of the N-glycosidic bond between deoxyribose and the pyrimidine base |
| Substrates | Cytosine and thymine in DNA; thymidine in enzymatic reactions |
| Enzymes | Human thymidine phosphorylase (TYMP) catalyzes arsenolytic depyrimidination of thymidine |
| Related processes | Base excision repair (BER), depurination, DNA methylation analysis |
What Is GO:0045008?
Depyrimidination (GO:0045008) is the biological process in which the N-glycosidic bond linking a pyrimidine base, either cytosine (C) or thymine (T), to the deoxyribose sugar in the DNA backbone is cleaved. This cleavage removes the base and leaves behind an apyrimidinic site, also known as an AP site or abasic site, where the sugar-phosphate backbone remains intact but lacks the informational base. The process can occur spontaneously through hydrolysis, particularly under heat, or be catalyzed by specific enzymes such as thymidine phosphorylase. Depyrimidination is distinct from depurination, which involves loss of purine bases (adenine or guanine), although both generate AP sites.
Why Is depyrimidination Important in Cell Biology?
Depyrimidination is critically important because it is a major source of endogenous DNA damage that threatens genomic stability. The resulting AP sites are cytotoxic and mutagenic if not repaired, and they can lead to single-strand breaks, base substitutions, and cell death. Understanding depyrimidination is therefore central to research on DNA repair mechanisms, aging, cancer, and the mechanisms of action of DNA-damaging agents. Moreover, the process is exploited in biotechnology, such as in methods for quantifying DNA methylation, and its enzymatic counterpart, thymidine phosphorylase, is a target for drug design.
• Depyrimidination generates apyrimidinic (AP) sites, which are among the most common endogenous DNA lesions.
• Spontaneous depyrimidination occurs under physiological conditions and is accelerated by heat, contributing to the instability of the genome.
• The process is a source of mutations: depyrimidination hotspots correlate with base substitution mutations induced by neocarzinostatin chromophore.
• Enzymatic depyrimidination by human thymidine phosphorylase is involved in pyrimidine metabolism and is a target for anticancer and antiviral drugs.
• The chemistry of depyrimidination is influenced by substituents on the pyrimidine ring, affecting the rate of base loss.
• Depyrimidination is used analytically in a one-pot fluorescence tagging strategy for global DNA methylation quantification.
• Understanding depyrimidination is essential for studying base excision repair (BER) and other DNA repair pathways.
• The process is relevant to aging and age-related diseases due to cumulative DNA damage.
• Depyrimidination can be studied using synthetic oligonucleotide models, such as 3'-N-phosphoramidate analogs, to probe hydrolytic reactions.
• Research on depyrimidination informs the development of CRISPR-based models to study DNA repair genes and their roles in disease.
What Happens During depyrimidination?
Spontaneous Hydrolytic Cleavage of the Glycosidic Bond
In simple terms: The bond holding a DNA base to its sugar can break on its own when exposed to water and heat.
Depyrimidination begins with the hydrolysis of the N-glycosidic bond that connects the pyrimidine base (cytosine or thymine) to the 2'-deoxyribose sugar in DNA. This reaction occurs spontaneously in neutral solution and is temperature-dependent, as demonstrated by Lindahl and colleagues, who showed heat-induced depyrimidination of deoxyribonucleic acid. The rate of this reaction is influenced by the chemical environment, including the presence of substituents on the pyrimidine ring; for example, 5-halo substituents on 2'-deoxyuridines affect the thermal depyrimidination of the glycosidic bond. The result is an apyrimidinic (AP) site, where the sugar-phosphate backbone remains but the base is lost.
Enzymatic Depyrimidination by Thymidine Phosphorylase
In simple terms: Some enzymes can deliberately remove a pyrimidine base from a nucleoside, as part of normal metabolism.
In addition to spontaneous hydrolysis, depyrimidination can be catalyzed by enzymes. Human thymidine phosphorylase catalyzes the arsenolytic depyrimidination of thymidine, cleaving the glycosidic bond to release thymine and 2-deoxy-D-ribose 1-phosphate. Transition state analysis of this reaction has provided insights into its catalytic mechanism. This enzymatic activity is important in pyrimidine salvage and metabolism, and the enzyme is a target for chemotherapeutic drugs.
Formation of Apyrimidinic (AP) Sites and Their Consequences
In simple terms: When a base is lost, the DNA has a gap that can cause problems during replication and transcription.
The immediate product of depyrimidination is an apyrimidinic (AP) site, also called an abasic site. AP sites are highly reactive and can lead to DNA strand breaks or mutations if not repaired. The presence of AP sites is a common form of endogenous DNA damage, and their accumulation is associated with mutagenesis and cell death. Studies on neocarzinostatin chromophore have shown that depyrimidination hotspots at sequence AGC correlate with base substitution mutations in the cI gene of lambda phage, directly linking base loss to mutagenesis.
Chemical Models and Analytical Applications
In simple terms: Scientists can study depyrimidination using synthetic DNA-like molecules and even use it in lab tests.
Depyrimidination can be modeled chemically using synthetic nucleoside analogs. For instance, hydrolytic reactions of 3'-N-phosphoramidate and 3'-N-thiophosphoramidate analogs of thymidylyl-3',5'-thymidine have been studied to understand the cleavage of the glycosidic bond. Furthermore, depyrimidination has been harnessed in analytical chemistry: a novel one-pot fluorescence tagging and depyrimidination strategy enables quantification of global DNA methylation, demonstrating the practical utility of this process in epigenetics research.
Key Genes Involved in GO:0045008 depyrimidination
The following genes and proteins are directly implicated in depyrimidination or in the repair of its products, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TYMP | Encodes thymidine phosphorylase, which catalyzes arsenolytic depyrimidination of thymidine | Target for anticancer and antiviral drugs; model for enzymatic depyrimidination |
| APEX1 | Major apurinic/apyrimidinic endonuclease in base excision repair, processing AP sites generated by depyrimidination | Key repair enzyme; knockout models show accumulation of AP sites |
| XRCC1 | Scaffold protein in base excision repair that coordinates repair of AP sites | Defects lead to sensitivity to DNA-damaging agents |
| POLB | DNA polymerase beta fills gaps after AP site processing in base excision repair | Important for repair of depyrimidination-induced lesions |
| LIG3 | DNA ligase III seals nicks during base excision repair | Deficiency causes accumulation of DNA breaks |
| PARP1 | Poly(ADP-ribose) polymerase 1 detects DNA strand breaks and recruits repair factors | Target for cancer therapy; involved in repair of AP site-derived breaks |
| OGG1 | 8-oxoguanine DNA glycosylase, a base excision repair enzyme | Model for glycosylase-mediated base removal |
| MUTYH | Adenine DNA glycosylase involved in repair of oxidative damage | Mutations cause colorectal cancer; relevant to base loss repair |
| NEIL1 | Nei-like DNA glycosylase involved in base excision repair | Participates in repair of oxidized bases |
| NEIL2 | Nei-like DNA glycosylase involved in base excision repair | Important for repair in transcribed regions |
| NTHL1 | Endonuclease III-like DNA glycosylase | Bifunctional glycosylase with AP lyase activity |
| TDG | Thymine DNA glycosylase, removes thymine from G:T mismatches | Involved in epigenetic regulation and base excision repair |
| UNG | Uracil DNA glycosylase, removes uracil from DNA | Model for glycosylase specificity |
| SMUG1 | Single-strand selective monofunctional uracil DNA glycosylase | Backup for UNG in uracil removal |
| MBD4 | Methyl-CpG binding domain protein 4, a glycosylase | Links DNA methylation to repair |
| FEN1 | Flap endonuclease involved in long-patch base excision repair | Processes repair intermediates |
| PCNA | Proliferating cell nuclear antigen, coordinates repair and replication | Essential for long-patch BER |
| RPA1 | Replication protein A, binds single-stranded DNA during repair | Protects DNA intermediates during repair |
How Is depyrimidination Regulated?
Depyrimidination itself is a chemical process that is not directly regulated by cellular signaling pathways, but its consequences are managed by the base excision repair (BER) pathway, which is subject to regulation. For example, melatonin has been shown to modulate the DNA repair system, including BER, by influencing the expression and activity of repair enzymes. The repair of AP sites generated by depyrimidination involves a coordinated cascade of enzymes including APEX1, POLB, and LIG3, whose activities can be regulated at the transcriptional and post-translational levels. Additionally, the enzymatic depyrimidination catalyzed by thymidine phosphorylase is regulated by substrate availability and is a target for pharmacological inhibition.
depyrimidination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TYMP | Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE); cancer angiogenesis | Knockout of TYMP in cell lines to study thymidine accumulation |
| APEX1 | Cancer predisposition; neurodegeneration | Point mutation of catalytic residues to assess AP site repair |
| POLB | Cancer; sensitivity to DNA-damaging agents | Knockout in cancer cell lines to test chemosensitivity |
| XRCC1 | Cancer; impaired BER | Knock-in of patient mutations to study repair deficiency |
| MBD4 | Colorectal cancer; epigenetic regulation | Overexpression to study glycosylase activity |
Cancer and Mutagenesis
Depyrimidination contributes to mutagenesis and genomic instability, which are hallmarks of cancer. The correlation of depyrimidination hotspots with base substitution mutations induced by neocarzinostatin chromophore demonstrates a direct link between base loss and mutation. Defects in the repair of AP sites, such as those caused by mutations in APEX1 or POLB, can lead to increased mutation rates and cancer predisposition. Furthermore, thymidine phosphorylase (TYMP) is overexpressed in many cancers and is associated with angiogenesis and poor prognosis, making it a target for anticancer therapy.
Neurodegeneration and Aging
Accumulation of DNA damage, including AP sites from depyrimidination, is a feature of aging and neurodegenerative diseases. Impaired DNA repair capacity, as seen in defects in base excision repair genes, can lead to neuronal loss and neurodegeneration. Melatonin, a regulator of DNA repair, has been proposed to protect against neurodegeneration by enhancing repair of oxidative and alkylation damage, which includes AP sites.
Metabolic and Mitochondrial Disorders
Mutations in TYMP cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), a rare metabolic disorder characterized by thymidine phosphorylase deficiency and accumulation of thymidine. This highlights the importance of enzymatic depyrimidination in nucleotide homeostasis and mitochondrial function.
From depyrimidination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TYMP affect cellular sensitivity to thymidine analogs? | TYMP knockout cell line |
| Does a specific APEX1 mutation impair AP site repair? | Point mutation knock-in of APEX1 |
| Can a tagged APEX1 be used to track repair dynamics? | Tagged knock-in of APEX1 with fluorescent protein |
| Does overexpression of POLB increase resistance to alkylating agents? | POLB overexpression cell line |
| What is the role of MBD4 in repairing depyrimidination-induced mutations? | MBD4 knockout and overexpression models |
| Can CRISPR library screening identify genes that modulate depyrimidination sensitivity? | Genome-wide CRISPR knockout library screening |
How to Study the depyrimidination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Aldehyde-reactive probe assay | Quantification of AP sites | Measuring depyrimidination in genomic DNA |
| Fluorescence tagging with depyrimidination | Global DNA methylation levels | Epigenetics research |
| Transition state analysis | Enzymatic mechanism of thymidine phosphorylase | Drug design |
| Lambda phage cI mutation assay | Base substitution mutations | Mutagenesis studies |
| Synthetic oligonucleotide hydrolysis | Chemical stability of glycosidic bonds | Modeling depyrimidination |
| CRISPR knockout screening | Gene essentiality and sensitivity | Identifying repair genes |
| RNA-seq | Transcriptional responses to DNA damage | Studying repair pathway regulation |
| Proteomics | Protein expression and modifications | Analyzing repair complex assembly |
Detection of AP Sites
Apyrimidinic sites generated by depyrimidination can be detected using aldehyde-reactive probes or by enzymatic assays with AP endonucleases. These methods allow quantification of base loss in genomic DNA.
Fluorescence Tagging and Methylation Quantification
A one-pot fluorescence tagging and depyrimidination strategy has been developed for quantification of global DNA methylation. This method exploits depyrimidination to expose specific sites for tagging, enabling sensitive detection.
Transition State Analysis
Transition state analysis of enzymatic depyrimidination, such as that catalyzed by human thymidine phosphorylase, provides insights into the catalytic mechanism and can guide inhibitor design.
Mutagenesis Assays
The mutagenic consequences of depyrimidination can be studied using reporter genes, such as the cI gene of lambda phage, where depyrimidination hotspots correlate with base substitution mutations.
How CRISPR Can Be Used to Study GO:0045008 depyrimidination
Knockout
CRISPR knockout of genes involved in depyrimidination and repair, such as TYMP, APEX1, or POLB, allows researchers to assess their roles in cellular responses to base loss. For example, TYMP knockout cells can be used to study thymidine accumulation and sensitivity to thymidine analogs.
Point Mutation
Introducing specific point mutations in genes like APEX1 or POLB can mimic patient-derived mutations and help dissect catalytic residues required for repair of depyrimidination-induced AP sites.
Knock-in
Knock-in of tagged versions of repair proteins, such as APEX1-GFP, enables real-time imaging of repair dynamics at AP sites. This approach can reveal the spatiotemporal organization of base excision repair.
Overexpression
Overexpression of genes like POLB or MBD4 can test whether increased repair capacity protects against depyrimidination-induced damage or alters sensitivity to DNA-damaging agents.
How EDITGENE Supports depyrimidination Research
Researchers studying depyrimidination-related genes often need to determine whether a candidate gene is causally involved in the repair or generation of AP sites, and CRISPR-based models provide a precise way to test these hypotheses.
Contact EDITGENE today to design your custom CRISPR model for depyrimidination research.
Frequently Asked Questions About depyrimidination
What is depyrimidination?
Depyrimidination is the biological process in which the bond between the DNA sugar backbone and a cytosine or thymine base is broken, removing the base and leaving an apyrimidinic (AP) site.
What genes are involved in depyrimidination?
Genes involved include TYMP, which encodes thymidine phosphorylase that catalyzes enzymatic depyrimidination, and DNA repair genes such as APEX1, POLB, and XRCC1 that process AP sites.
What is the difference between depyrimidination and depurination?
Depyrimidination removes pyrimidine bases (C or T), while depurination removes purine bases (A or G). Both generate AP sites, but the relative ease of each reaction has been compared in nucleosides.
How does depyrimidination cause mutations?
Depyrimidination creates AP sites that can be bypassed by DNA polymerases, leading to base substitutions. Hotspots of depyrimidination correlate with mutations induced by agents like neocarzinostatin.
What is the role of thymidine phosphorylase in depyrimidination?
Human thymidine phosphorylase catalyzes the arsenolytic depyrimidination of thymidine, cleaving it to thymine and 2-deoxy-D-ribose 1-phosphate.
How is depyrimidination detected in the lab?
It can be detected using aldehyde-reactive probes that quantify AP sites, or through fluorescence tagging strategies that exploit depyrimidination for DNA methylation analysis.
Is depyrimidination spontaneous or enzymatic?
It can be both: spontaneous hydrolysis occurs under physiological conditions and with heat, while enzymes like thymidine phosphorylase catalyze the reaction.
What diseases are associated with defects in depyrimidination repair?
Defects in repair of AP sites are linked to cancer, neurodegeneration, and aging. Mutations in TYMP cause mitochondrial neurogastrointestinal encephalomyopathy.
Can CRISPR be used to study depyrimidination?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study genes involved in depyrimidination and AP site repair.
What are the research methods for studying depyrimidination?
Methods include AP site detection assays, transition state analysis, mutagenesis assays, and CRISPR screening.
Conclusion
Depyrimidination (GO:0045008) is a fundamental DNA damage process that removes cytosine or thymine bases, generating mutagenic AP sites. Its study is essential for understanding genome stability, DNA repair, and diseases such as cancer and neurodegeneration. The verified literature provides a solid foundation for mechanistic and therapeutic research. EDITGENE offers comprehensive CRISPR services to facilitate functional studies of depyrimidination-related genes, from knockout to library screening, empowering researchers to uncover new insights into this critical biological process.
References
- 1. Liao X et al.. 2023. A novel one-pot fluorescence tagging and depyrimidination strategy for quantification of global DNA methylation.. Anal Chim Acta 1239:340636 PMID: 36628742
- 2. Schwartz PA et al.. 2011. Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase.. Biochemistry 50(8):1412-20 PMID: 21222488
- 3. Lindahl T et al.. 1973. Heat-induced depyrimidination of deoxyribonucleic acid in neutral solution.. Biochemistry 12(25):5151-4 PMID: 4600811
- 4. Povirk LF et al.. 1986. Base substitution mutations induced in the cI gene of lambda phage by neocarzinostatin chromophore: correlation with depyrimidination hotspots at the sequence AGC.. Nucleic Acids Res 14(3):1417-26 PMID: 2937016
- 5. Olafsson PG et al.. 1974. A comparative study of the relative ease of thermolytic depurination vs. depyrimidination in 2'-deoxynucleosides.. Can J Biochem 52(11):997-1002 PMID: 4547677
- 6. Olafsson PG et al.. 1974. The influence of 5-halo substituents on the thermal depyrimidination of the glycosidic bond in 2'-deoxyuridines.. Arch Biochem Biophys 165(1):46-50 PMID: 4280265
- 7. Mir SM et al.. 2022. Melatonin: A smart molecule in the DNA repair system.. Cell Biochem Funct 40(1):4-16 PMID: 34672014
- 8. Ora M et al.. 2004. Hydrolytic reactions of 3'-N-phosphoramidate and 3'-N-thiophosphoramidate analogs of thymidylyl-3',5'-thymidine.. Org Biomol Chem 2(4):593-600 PMID: 14770239
